These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 15501399
1. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. Drouin EE, Glickstein LJ, Steere AC. J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399 [Abstract] [Full Text] [Related]
2. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT, Steere AC. Arthritis Rheum; 1999 Sep; 42(9):1813-22. PubMed ID: 10513794 [Abstract] [Full Text] [Related]
4. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters. Lovrich SD, Jobe DA, Schell RF, Callister SM. Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749 [Abstract] [Full Text] [Related]
5. Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis. Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC. Mol Immunol; 2008 Jan; 45(1):180-9. PubMed ID: 17555819 [Abstract] [Full Text] [Related]
8. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. Shanafelt MC, Anzola J, Soderberg C, Yssel H, Turck CW, Peltz G. J Immunol; 1992 Jan 01; 148(1):218-24. PubMed ID: 1370170 [Abstract] [Full Text] [Related]
9. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W, Huang X, Yang X, Dunn JJ, Luft BJ, Koide S, Lawson CL. J Mol Biol; 2000 Oct 06; 302(5):1153-64. PubMed ID: 11183781 [Abstract] [Full Text] [Related]
10. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis. Busch DH, Jassoy C, Brinckmann U, Girschick H, Huppertz HI. J Immunol; 1996 Oct 15; 157(8):3534-41. PubMed ID: 8871653 [Abstract] [Full Text] [Related]
11. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Kamradt T, Lengl-Janssen B, Strauss AF, Bansal G, Steere AC. Infect Immun; 1996 Apr 15; 64(4):1284-9. PubMed ID: 8606091 [Abstract] [Full Text] [Related]
12. Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of lyme borreliosis patients. Floris R, Menardi G, Bressan R, Trevisan G, Ortenzio S, Rorai E, Cinco M. New Microbiol; 2007 Oct 15; 30(4):399-410. PubMed ID: 18080675 [Abstract] [Full Text] [Related]
13. [Immunopathology of Lyme arthritis]. Pancewicz SA, Rutkowski R, Rutkowski K, Zajkowska JM, Kondrusik M. Pol Merkur Lekarski; 2007 Aug 15; 23(134):141-4. PubMed ID: 18044347 [Abstract] [Full Text] [Related]
15. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity? Bolz DD, Weis JJ. Autoimmunity; 2004 Aug 15; 37(5):387-92. PubMed ID: 15621562 [Abstract] [Full Text] [Related]
16. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype. Wilske B, Jauris-Heipke S, Lobentanzer R, Pradel I, Preac-Mursic V, Rössler D, Soutschek E, Johnson RC. J Clin Microbiol; 1995 Jan 15; 33(1):103-9. PubMed ID: 7699024 [Abstract] [Full Text] [Related]
17. Lyme disease: uphill struggle. Abbott A. Nature; 2006 Feb 02; 439(7076):524-5. PubMed ID: 16452949 [No Abstract] [Full Text] [Related]
18. NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies. Huang X, Yang X, Luft BJ, Koide S. J Mol Biol; 1998 Aug 07; 281(1):61-7. PubMed ID: 9680475 [Abstract] [Full Text] [Related]
19. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Nassal M, Skamel C, Kratz PA, Wallich R, Stehle T, Simon MM. Eur J Immunol; 2005 Feb 07; 35(2):655-65. PubMed ID: 15668917 [Abstract] [Full Text] [Related]
20. An ospA frame shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies. Fikrig E, Liu B, Fu LL, Das S, Smallwood JI, Flavell RA, Persing DH, Schoen RT, Barthold SW, Malawista SE. J Immunol; 1995 Dec 15; 155(12):5700-4. PubMed ID: 7499856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]